Skip to main content
MEDINET Co., Ltd. logo

MEDINET Co., Ltd. — Investor Relations & Filings

Ticker · 2370 ISIN · JP3920990003 T Manufacturing
Open in API
Filings indexed 63 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country JP Japan
Listing T 2370

About MEDINET Co., Ltd.

https://www.medinet-inc.co.jp/english/

MEDINET Co., Ltd. is a Contract Development and Manufacturing Organization (CDMO) specializing in regenerative medicine and cell therapy. The company provides comprehensive, one-stop solutions across the entire value chain, from pre-clinical research and process development to manufacturing and commercial launch. Its services encompass technology transfer, quality control, and quality assurance for regenerative medical products, investigational products, and specified cell products. MEDINET operates an advanced cell processing facility (CPF) designed to comply with international standards such as GCTP, leveraging extensive experience since 1999 to support clients in developing and manufacturing their cellular therapies.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 88% confidence The document is a short confirmation letter (“確認書”) filed under the Financial Instruments and Exchange Act, attesting that the half-year report is properly prepared, but it does not include actual financial statements or substantive data itself. It is therefore an officer certification rather than the interim report. Under the Certification Rule, such attestations are classified as Regulatory Filings (RNS).
2026-05-14 Japanese
半期報告書－第31期(2025/10/01－2026/09/30)
Interim / Quarterly Report Classification · 97% confidence The document is a Japanese "半期報告書" (Half-Year Report) filed under Financial Instruments and Exchange Act Article 24-5, covering the interim accounting period (October 1, 2025 to March 31, 2026). It contains detailed interim financial statements (income, assets, cash flows), management’s analysis of results, segment disclosures, and other substantive financial data for the six-month period. It is not merely an announcement or link to a report but the full interim report itself. This matches the definition of an Interim / Quarterly Report (IR). H1 2026
2026-05-14 Japanese
訂正有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction of Securities Registration Statement' (訂正有価証券届出書) filed with the Kanto Local Finance Bureau by MEDINET Co., Ltd. It details the issuance of new share acquisition rights (第20回新株予約権証券), including terms, conditions, and the purpose of the capital raise. This type of filing is a standard regulatory document for capital changes and financing activities in Japan, which falls under the 'Share Issue/Capital Change' category.
2025-12-17 Japanese
確認書
Audit Report / Information Classification · 98% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. This is a mandatory internal control certification that accompanies the Annual Securities Report (Yukashoken Hokokusho). Since it is a regulatory filing confirming the accuracy of the annual report and does not contain the full financial statements or the report itself, it falls under the category of Regulatory Filings (RNS). FY 2025
2025-12-17 Japanese
有価証券報告書－第30期(2024/10/01－2025/09/30)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of a 10-K Annual Report. It contains detailed financial statements, business overviews, and historical data for the fiscal year ending September 30, 2025. It is a comprehensive annual filing submitted to the Kanto Local Finance Bureau, not an announcement or a summary. FY 2025
2025-12-17 Japanese
訂正有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 98% confidence The document is a 'Correction of Securities Registration Statement' (訂正有価証券届出書) filed with the Kanto Local Finance Bureau. It details the issuance of new share acquisition rights (stock options/warrants) by MEDINET Co., Ltd. This type of filing is a regulatory document required under the Financial Instruments and Exchange Act in Japan for capital raising activities. Since it involves the issuance of new shares/warrants to raise capital, it falls under the 'Share Issue/Capital Change' category.
2025-12-05 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.